Skip to content
777 Sourcing.

From the company

GenrAb is harnessing the power of human immunity to develop therapies that can protect and treat patients with neurological diseases. Its proprietary Antibody Gene Signature (AGS) technology has identified over 400 potentially therapeutic fully-human monoclonal antibodies (mAbs) to treat neurological disorders. Its lead mAb, TGM-010, targets a conserved neurodegenerative pathway and has demonstrated reduced disability in preclinical models.

Location: WESTLAKE, TX, USFounded: 2022Capabilities: 3Facilities: 1

Products & services offered

Facilities

Headquarters

1401 HAWTHORN WAY, WESTLAKE, TX 76262-9034, US

View map

Send your requirements

Quantities, certifications, and timing.

Send your requirements · Supplier responds with a quote · Compare and decide

Similar products and services